Filing Details
- Accession Number:
- 0001179110-15-003429
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-25 16:54:39
- Reporting Period:
- 2015-02-23
- Filing Date:
- 2015-02-25
- Accepted Time:
- 2015-02-25 16:54:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145460 | Alere Inc. | ALR | In Vitro & In Vivo Diagnostic Substances (2835) | 043565120 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632754 | Mark Gladwell | 51 Sawyer Road, Suite 200 Waltham MA 02453 | Senior Vp, Global Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-23 | 12,500 | $28.03 | 13,292 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-23 | 12,500 | $44.61 | 792 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-02-23 | 792 | $44.66 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-02-23 | 12,500 | $0.00 | 12,500 | $28.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-05-24 | No | 4 | M | Direct |
Footnotes
- Represents same day exercise and sale of expiring stock options.
- Option vested in four equal installments on 5/24/06, 5/24/07, 5/24/08 and 5/24/09.
- This derivative security does not have a price.
- The price reported is a weighted average price. These shares were sold in approximately 79 separate transactions at prices ranging from $44.58 to $44.66, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was effected.
- The price reported is a weighted average price. These shares were sold in approximately 7 separate transactions at prices ranging from $44.66 to $44.67, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
